Показати скорочений опис матеріалу

dc.contributor.author Dudnyk, V. M. en
dc.contributor.author Buhlova, N. O. en
dc.contributor.author Morozova, I. V. en
dc.contributor.author Kukuruza, T. Y. en
dc.date.accessioned 2023-02-20T10:01:17Z
dc.date.available 2023-02-20T10:01:17Z
dc.date.issued 2022
dc.identifier.citation The effect of the reparative action drug in treatment of pediatric duodenal ulcer / V. M. Dudnyk, N. O. Buhlova, I. V. Morozova, T. Y. Kukuruza // Perinatology and Pediatrics. - 2022. - № 4 (92). - P. 33-36. uk_UA
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/6044
dc.description.abstract Digestive tract diseases occupy one of the first places in the structure of childhood pathology, including duodenal ulcers (DU), the development of which in 70–100% of cases is associated with H.pylori infection. It is found that the important role in the development of inflammatory process in digestive tract have toll-like receptors 4 (TLR4), due to reactiveness to H.pylori. It is proved that growth factors, in particular epidermal growth factor (EGF), are able to influence on the healing processes in the mucous membrane. It is advisable to include drugs of reparative action in complex treatment of pediatric DU. en
dc.language.iso en en
dc.subject children en
dc.subject duodenal ulcer en
dc.subject drug of reparative function en
dc.subject Helicobacter pylori
dc.title The effect of the reparative action drug in treatment of pediatric duodenal ulcer en
dc.type Article en


Файли цього елементу

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу

Пошук


Перегляд

Мій обліковий запис

Статистика